These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 33014189)
1. Diagnostic and Prognostic Potentials of Long Noncoding RNA ELF3-AS1 in Glioma Patients. Mei JC; Yan G; Mei SQ Dis Markers; 2020; 2020():8871746. PubMed ID: 33014189 [TBL] [Abstract][Full Text] [Related]
2. Analysis of Long Noncoding RNA ZNF667-AS1 as a Potential Biomarker for Diagnosis and Prognosis of Glioma Patients. Yuan Q; Gao C; Lai XD; Chen LY; Lai TB Dis Markers; 2020; 2020():8895968. PubMed ID: 33282010 [TBL] [Abstract][Full Text] [Related]
3. LncRNA ELF3-AS1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma. Chen T; Zhu C; Wang X; Pan Y Can J Gastroenterol Hepatol; 2021; 2021():8323487. PubMed ID: 34336727 [TBL] [Abstract][Full Text] [Related]
4. ELF3-AS1 contributes to gastric cancer progression by binding to hnRNPK and induces thrombocytosis in peripheral blood. Song S; He X; Wang J; Wang R; Wang L; Zhao W; Wang Y; Zhang Y; Yu Z; Miao D; Xue Y Cancer Sci; 2021 Nov; 112(11):4553-4569. PubMed ID: 34418240 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma. He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316 [TBL] [Abstract][Full Text] [Related]
6. Up‑regulation of lncRNA PXN-AS1-L is associated with unfavorable prognosis in patients suffering from glioma. Shang F; Du SW; Ma XL Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8950-8955. PubMed ID: 31696482 [TBL] [Abstract][Full Text] [Related]
7. LncRNA ELF3-AS1 Promotes Non-Small Cell Lung Cancer Cell Invasion and Migration by Downregulating miR-212. Zhang Z; Nong L; Chen ML; Gu XL; Zhao WW; Liu MH; Cheng WW Cancer Biother Radiopharm; 2022 Mar; 37(2):119-124. PubMed ID: 32598181 [TBL] [Abstract][Full Text] [Related]
8. Expression of lncRNA FGD5-AS1 correlates with poor prognosis in melanoma patients. Gao Y; Zhu H; Mao Q J Gene Med; 2020 Dec; 22(12):e3278. PubMed ID: 32997827 [TBL] [Abstract][Full Text] [Related]
9. Value of long non-coding RNA HAS2-AS1 as a diagnostic and prognostic marker of glioma. You A; Gu J; Wang J; Li J; Zhang Y; Rao G; Ge X; Zhang K; Gao X; Wang D Neurologia (Engl Ed); 2024 May; 39(4):353-360. PubMed ID: 38616063 [TBL] [Abstract][Full Text] [Related]
10. LncRNA ELF3-AS1 inhibits gastric cancer by forming a negative feedback loop with SNAI2 and regulates ELF3 mRNA stability via interacting with ILF2/ILF3 complex. Li D; Shen L; Zhang X; Chen Z; Huang P; Huang C; Qin S J Exp Clin Cancer Res; 2022 Dec; 41(1):332. PubMed ID: 36457025 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic significance of long noncoding RNA SSTR5-AS1 in patients with gastric cancer. Cheng Y; Di J; Wu J; Shi HT; Zou BC; Zhang Y; Xie DH Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5385-5390. PubMed ID: 32495873 [TBL] [Abstract][Full Text] [Related]
12. Expression of long non-coding RNA MAGI2‑AS3 in human gliomas and its prognostic significance. Chen XD; Zhu MX; Wang SJ Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3455-3460. PubMed ID: 31081100 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway. Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Immune-Related lncRNA SBF2-AS1 in Diffuse Lower-Grade Glioma. Zhang Q; Liu XJ; Li Y; Ying XW; Chen L Technol Cancer Res Treat; 2021; 20():15330338211011966. PubMed ID: 34159865 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA ZEB1-AS1 promotes glioma cell proliferation, migration and invasion through regulating miR-577. Wei N; Wei H; Zhang H Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3085-3093. PubMed ID: 29863254 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of long noncoding RNA LEF1-AS1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma. Zong MZ; Feng WT; Du N; Yu XJ; Yu WY Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7929-7934. PubMed ID: 31599448 [TBL] [Abstract][Full Text] [Related]
17. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma. Lv QL; Hu L; Chen SH; Sun B; Fu ML; Qin CZ; Qu Q; Wang GH; He CJ; Zhou HH Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589728 [TBL] [Abstract][Full Text] [Related]
18. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer. Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway. Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164 [TBL] [Abstract][Full Text] [Related]
20. LncRNA ADAMTS9-AS1 knockdown suppresses cell proliferation and migration in glioma through downregulating Wnt/β-catenin signaling pathway. Zhou C; Zhao H; Wang S; Dong C; Yang F; Zhang J Bosn J Basic Med Sci; 2022 Jun; 22(3):395-402. PubMed ID: 34923953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]